切换导航
关闭
  • 菜单
  • Setting

Signaling Pathways - sodium channel - TAK1 - Insulin and Insulin-like Receptors - Squalene epoxidases

13件产品中的 1-10

页面
每页
清除全部
  1. (5Z)-7-Oxozeaenol
    B7443 (5Z)-7-Oxozeaenol
     1 Citation
    Target: TAK1
    Summary: TAK1促分裂原活化蛋白激酶激酶激酶(MAPKKK)抑制剂
      <9.06 mg/mL
      insoluble in ethanol
  2. Ibutilide Fumarate
    B2278 Ibutilide Fumarate
    中文名: 富马酸伊布利特
    Target: Voltage-gated Potassium (KV) Channels|Voltage-gated Calcium Channels (CaV)|sodium channel
    Summary: III类抗心律失常药物
      ≥25.6 mg/mL
      ≥16.4 mg/mL
  3. Lamotrigine
    B2249 Lamotrigine
     1 Citation
    中文名: 拉莫三嗪
    Target: 5-HT receptors|sodium channel
    Summary: 5-HT抑制剂,钠通道阻断剂
      ≥12.3 mg/mL
      insoluble in H2O
  4. Butenafine HCl
    B1901 Butenafine HCl
    中文名: 盐酸布替萘芬
    Target: Squalene epoxidases
    Summary: 合成苄胺抗真菌剂
      ≥17.55 mg/mL
      insoluble in H2O
  5. Terbinafine HCl
    B2047 Terbinafine HCl
    中文名: 盐酸特比萘芬
    Target: Squalene epoxidases
    Summary: 有效的非竞争性角鲨烯环氧酶抑制剂
      ≥16.3 mg/mL
      insoluble in H2O
  6. Terbinafine
    A8533 Terbinafine
    中文名: 特比萘芬
    Target: Squalene epoxidases
    Summary: 烯丙胺抗真菌剂
      ≥11.9 mg/mL
      insoluble in H2O
  7. GSK1838705A
    A8440 GSK1838705A
    Target: Insulin and Insulin-like Receptors|ALK
    Summary: ATP竞争性IGF-IR/IR/ALK抑制剂
      ≥26.65 mg/mL
      insoluble in H2O
  8. GSK1904529A
    A1302 GSK1904529A
    Target: Insulin and Insulin-like Receptors
    Summary: IGF-1R/IR 选择性抑制剂
      ≥42.6 mg/mL
      insoluble in H2O
  9. BMS-754807
    A1185 BMS-754807
    Target: Insulin and Insulin-like Receptors
    Summary: 有效的、选择性的IGF-1R和InsR抑制剂
      ≥23.05 mg/mL
      insoluble in H2O
  10. NB-598 hydrochloride
    A3646 NB-598 hydrochloride
    Target: Squalene epoxidases
    Summary: SE抑制剂
      ≥54 mg/mL
      insoluble in H2O

13件产品中的 1-10

页面
每页